Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy

Magnetic Resonance in Medicine

Volumn 60, Issue 5, 2008, Pages 1232-1236

  Waters, Emily A ^a,b   Chen, Junjie ^a   Yang, Xiaoxia ^a   Zhang, Huiying ^a   Neumann, Robert ^a   Santeford, Andrea ^a   Arbeit, Jeffrey ^a   Lanza, Gregory M ^a,b   Wickline, Samuel A ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c C TRAIN Group   (United States)

Author keywords

Angiogenesis; Diffusion; Fluorine; Magnetic resonance spectroscopy

Indexed keywords

BINDING SITES; BLOOD; DIFFUSION; FLUORINE; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROSCOPY; MAMMALS;

ANGIOGENESIS; BACKGROUND SIGNALS; DIFFUSION WEIGHTING; PERFLUOROCARBONS; REAL-TIME DETECTION; SPECIFIC DETECTION; STATIONARY SIGNAL; TARGETED CONTRAST AGENTS;

NANOPARTICLES;

CONTRAST MEDIUM; FLUORINE; FLUOROCARBON; NANOPARTICLE; RHODAMINE; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CANCER MODEL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DRUG BINDING; DRUG DIFFUSION; EAR; EXPERIMENTAL MOUSE; FLUORINE NUCLEAR MAGNETIC RESONANCE; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MOUSE; MOUSE STRAIN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; TUMOR VASCULARIZATION; UPREGULATION;

EID: 55749113494     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21794     Document Type: Article

References (16)

1. Caruthers SD, Neubauer AM, Hockett FD, Lamerichs R, Winter PM, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla. Invest Radiol 2006;41:305-312.
2. Winter PM, Cai K, Caruthers SD, Wickline SA, Lanza GM. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles. Expert Rev Med Devices 2007;4:137-145.
3. Sosnovik DE, Weissleder R. Emerging concepts in molecular MRI. Curr Opin Biotechnol 2007;18:4-10.
4. Thorek DL, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006;34:23-38.
5. Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, Sharkey AM, Miller JG, Gaffney PJ, Wickline SA. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996;94:3334-3340.
6. Schmieder AH, Winter PM, Caruthers SD, Harris TD, Williams TA, Allen JS, Lacy EK, Zhang H, Scott MJ, Hu G, Robertson JD, Wickline SA, Lanza GM. Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magn Reson Imaging 2005;53:621-627.
7. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003;108:2270-2274.
8. Arbeit JM, Munger K, Howley PM, Hanahan D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol 1994;68:4358-4368.
9. Smith-McCune K, Zhu YH, Hanahan D, Arbeit J. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res 1997;57:1294-1300.
10. Neil JJ, Ackerman JJH. Detection of pseudodiffusion in rat brain following blood substitution with perfluorocarbon. J Magn Reson 1992;97:194-201.
11. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66:259-267.
12. Wityak J, Tobin AE; DuPont Pharmaceuticals, assignee. Integrin receptor antagonists. USA patent 6130231. 2000.
13. Tomita Y, Kubis N, Calando Y, Tran DA, Méric P, Seylaz J, Pinard E. Long-term in vivo investigation of mouse cerebral microcirculation by fluorescence confocal microscopy in the area of focal ischemia. J Cereb Blood Flow Metab 2005;25:858-867.
14. Duong TQ, Kim SG. In vivo MR measurements of regional arterial and venous blood volume fractions in intact rat brain. Magn Reson Imaging 2000;43:393-402.
15. Arbeit JM, Riley RR, Huey B, Porter C, Kelloff G, Lubet R, Ward JM, Pinkel D. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. Cancer Res 1999;59:3610-3620.
16. Mitsunaga S, Clapper M, Litwin S, Watts P, Bauer B, Klein-Szanto AJ. Chemopreventive effect of difluoromethylornithine (DFMO) on mouse skin squamous cell carcinomas induced by benzo(a)pyrene. J Cell Biochem Suppl 1997;28-29:81-89.